Application of nitric oxide measurements in clinical conditions beyond asthma.

Andrei Malinovschi, Dora Ludviksdottir, Ellen Tufvesson, Giovanni Rolla, Leif Bjermer, Kjell Alving, Zuzana Diamant

Research output: Contribution to journalArticlepeer-review

Abstract

Fractional exhaled nitric oxide (FeNO) is a convenient, non-invasive method for the assessment of active, mainly Th2-driven, airway inflammation, which is sensitive to treatment with standard anti-inflammatory therapy. Consequently, FeNO serves as a valued tool to aid diagnosis and monitoring in several asthma phenotypes. More recently, FeNO has been evaluated in several other respiratory, infectious, and/or immunological conditions. In this short review, we provide an overview of several clinical studies and discuss the status of potential applications of NO measurements in clinical conditions beyond asthma.
Original languageEnglish
Article number28517
JournalEuropean clinical respiratory journal
Volume2
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Respiratory Medicine and Allergy

Fingerprint

Dive into the research topics of 'Application of nitric oxide measurements in clinical conditions beyond asthma.'. Together they form a unique fingerprint.

Cite this